Allosta
PrivateLast Round
Series A
Dec 30, 2025
Total Funding Raised
$2.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Allosta is a healthtech company that provides AI-powered personalized health management solutions based on metabolome and microbiome data analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Precision Medicine, Subscription Commerce
Business Model
B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allosta Comparables
Compare Allosta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HEM Pharma Inc. | 74% | |
| Macrogen Inc | 72% | |
| Genoplan | 71% |
Allosta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 30, 2025 | ||||
| Pre Seed | Nov 28, 2024 | ||||
| Seed | Dec 1, 2023 | ||||
| Seed | Oct 17, 2022 |
Allosta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NICE Investment Partners | Series A |
| Shinhan Venture Investment | Series A |
| NH Nonghyup Bank | Series A |
| Korea SMEs and Startups Agency | Pre Seed |
| Lotte Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
Added Brook Wassall, a startup in Biotechnology / Life Sciences, as a customer.
- May 26, 2026
Added Imweb, a technology/e-commerce SMB, as a customer.
Allosta Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Allosta's valuation, stock price, and market status.
Is BIOCOM a public or private company?
BIOCOM is a private company.
What is the current stock price of BIOCOM?
BIOCOM is a private company with no public stock price. No recent secondary market data is available.
How much is BIOCOM worth (valuation)?
Valuation information for BIOCOM is not publicly available.
Can I buy BIOCOM stock?
BIOCOM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BIOCOM's last funding round?
BIOCOM's most recent funding round was Series A on December 29, 2025.
Who are the main investors in BIOCOM?
Key investors in BIOCOM include NICE Investment Partners, Shinhan Venture Investment, NH Nonghyup Bank.
Will BIOCOM IPO soon?
No public IPO plans have been announced for BIOCOM.
How can I track BIOCOM secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BIOCOM's secondary market activity and sign up for updates.